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M
y 11-month-old daughter loves 
her baby bottles and sippy 
cups (ﬁ  rst-person narrative 
is from the viewpoint of Rebecca 
Roberts). But as I sit and watch her 
drink from them, I cringe, because I 
happen to be a scientist who studies a 
chemical found in those bottles and 
cups. I also know that some scientiﬁ  c 
research suggests that exposure to 
that compound, called bisphenol A 
(BPA), is detrimental to good health—
something I can’t help but think about 
as I watch my daughter use her sippy 
cup as a teething ring.
As a scientist, I depend on evidence, 
logic, and imagination to explain 
observations made in the laboratory. 
I then interpret and communicate my 
ﬁ  ndings to the scientiﬁ  c community 
and the public. As a mother, I strive 
to raise a healthy and happy child. I 
make daily decisions about what my 
baby does and does not do, in order to 
limit her exposure to danger. In both 
of my roles, I depend on information: 
nonbiased, factual, evidence-based 
information. The mother in me 
relies on my training as a scientist to 
objectively look at scientiﬁ  c data in 
order to determine personal choices 
for my daughter. But, like all people, 
I am not qualiﬁ  ed, nor do I have the 
time, to understand all scientiﬁ  c issues. 
I must rely on others—on the brokers 
of information: other scientists, medical 
personnel, the government, regulatory 
agencies, corporations, nonproﬁ  t 
organizations, and the media, to name 
a few. 
The purveyors of information are 
not necessarily as objective, however, in 
their interpretation and dissemination 
of scientiﬁ  c data as my scientiﬁ  c self 
would like them to be—inﬂ  uenced 
as they are by timing, money, 
convenience, politics, and countless 
other agendas. I can only hope that 
the “facts” I receive are objective. 
Moreover, I hope that any regulations 
stemming from this science are 
established for the beneﬁ  t of my family 
and society as a whole. But how is the 
information regarding the effect of 
BPA on human health being packaged 
and communicated to the general 
public? Let’s begin by understanding 
what BPA is and how our modern 
society relies on it.
In 1952, chemists working with BPA 
discovered that it could help form a 
hard, clear plastic called polycarbonate. 
Polycarbonates make such products 
as compact discs, sunglasses, bicycle 
helmets, water and milk bottles, baby 
bottles, food storage containers, 
tableware, plastic windows, bullet-
resistant laminate, cell phones, car 
parts, toys, and some medical devices 
such as incubators, dialysis machines, 
and blood oxygenators. BPA is also 
used to make certain resins that are 
commonly found in the linings of 
food cans to prevent corrosion, and it 
is present in some polyvinyl chloride 
(PVC) plastic products, in white dental 
ﬁ  llings, dental sealants, and in some 
ﬂ  ame retardants. In keeping with its 
widespread applications, BPA ranks 
among the highest-volume chemicals 
manufactured worldwide, with an 
annual production in 2003 of about 
13 billion kilograms [1,2]. Regulation 
requiring a signiﬁ  cant reduction in 
BPA production and use could have a 
dramatic economic impact and would 
likely require some changes in personal 
lifestyle. 
BPA has been shown to leach from 
water bottles and food cans into the 
packaged foodstuffs. It then enters the 
body through the digestive tract when 
those foods are consumed.  The level 
of BPA released from plastic depends 
on the age and wear of the plastic and 
on exposure to heat. For example, one 
study showed that small levels of BPA 
leached from baby bottles subjected 
to simulated normal uses, including 
boiling, washing with a bottle brush, 
and dishwashing [3]. Plastic tableware 
(such as those used in some schools) 
was also found to release BPA into hot 
vegetable soup [2]. Older, worn bottles 
and bowls released BPA more readily 
than newer products [2,3]. BPA is 
also present in rivers and streams and 
in drinking water, presumably due to 
leaching from plastic items in landﬁ  lls 
[4-6]. A survey by the Centers for 
Disease Control and Prevention found 
that approximately 95% of Americans 
have detectable levels of BPA in their 
bodies [7]. 
Naturally, the prevalence of human 
exposure leads to questions about 
safety and health. Although the plastic 
industry continues to assert that BPA 
is safe, the chemical’s endocrine-
disrupting properties raise concern 
about its potential to cause harm. BPA 
exposure affects the hormonal system, 
in particular, the pathway involving 
estrogen; its effects have been studied 
on cells, tissues, and whole organisms. 
In adult male mice and rats, effects 
of BPA exposure—abnormal sperm 
and reduced fertility—were reversed 
when exposure stopped [8]. Of the few 
human epidemiological studies, one 
revealed a relationship between BPA 
exposure and repeated miscarriage 
[9]. Additionally, BPA causes a human 
breast cancer cell line to proliferate, 
indicating that estrogen-sensitive tissues 
Babies, Bottles, and Bisphenol A: 
The Story of a Scientist-Mother
Aimee Quitmeyer, Rebecca Roberts*
Citation: Quitmeyer A, Roberts R (2007) Babies, 
bottles, and bisphenol A: The story of a scientist-
mother. PLoS Biol 5(7): e200. doi:10.1371/journal.
pbio.0050200
Copyright: © 2007 Quitmeyer and Roberts. This is 
an open-access article distributed under the terms 
of the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original 
author and source are credited. 
Abbreviations: BPA, bisphenol A
Aimee Quitmeyer is an undergraduate student and 
Rebecca Roberts is Associate Professor with the 
Department of Biology, Ursinus College, Collegeville, 
Pennsylvania, United States of America. Rebecca 
Roberts is also Associate Professor and Coordinator 
of the Biochemistry and Molecular Biology Program 
at Ursinus College, Collegeville, Pennsylvania, United 
States of America.
* To whom correspondence should be addressed. 
E-mail: rroberts@ursinus.edu
Essays articulate a speciﬁ  c perspective on a topic of 
broad interest to scientists.PLoS Biology  |  www.plosbiology.org 1400
and cells in the body may react similarly 
[10].
Many animal studies focus on the 
effect of BPA exposure during fetal 
development, when cells and tissues 
are especially susceptible to hormonal 
alterations. Not only does BPA disrupt 
proper functioning of the placenta 
during gestation, but it causes many 
deleterious health effects in offspring 
exposed in utero [11], including 
enlarged prostates, malformed urethra 
[12,13], and a higher risk of prostate 
cancer in male offspring [14], and 
genital tract alterations [12,13] and 
earlier puberty in female offspring 
[13]. Exposure also affects brain 
development, causing behavioral 
differences between males and females 
to be lost in offspring exposed in the 
uterus [15]. A similar correlation 
to human development is plausible. 
Indeed, BPA has been found in the 
bloodstream, placenta, cord blood, and 
fetal blood of humans at levels that are 
within the range studied in many of the 
animal models [16]. 
Although BPA was not used in 
plastics manufacturing until the 1950s, 
its hormonal activity was reported 
in 1936 [17]. For decades, products 
containing BPA were shown not to 
release the compound, and thus these 
products were deemed safe. Indeed, 
the current Environmental Protection 
Agency (EPA) regulation regarding 
allowable levels of BPA exposure 
is based on these early ﬁ  ndings. As 
recently as 1999, an ofﬁ  cial of the 
Food and Drug Administration (FDA) 
stated that no BPA was detected 
in liquid stored in baby bottles 
under typical use conditions [18]. 
That same year, however, scientiﬁ  c 
techniques progressed such that very 
small levels of BPA could ﬁ  nally be 
measured accurately. Levels as low 
as parts per billion (ppb) are now 
routinely detected in the laboratory. 
Unfortunately, the ability to detect such 
low levels in a laboratory environment 
is often not good enough, since tissues 
and cells can respond to levels of BPA 
that are 100 times lower [19]. The ﬁ  rst 
such study showing a detrimental effect 
of BPA at very low doses was published 
in 1997, and since then, over 100 other 
studies have been published [19,20]. 
Let’s step back a moment and 
consider the roles of United States 
regulatory agencies such as the FDA 
and the EPA in determining the so-
called safe human exposure level for 
a chemical. Founded in 1906 the FDA 
focuses on ensuring safety of food, 
drugs, and medical products. Much 
later, in 1970, the EPA was established 
to protect human health in general 
and safeguard the environment by 
consolidating the varied efforts of 
research, monitoring, standard-setting, 
and enforcement. Six years after 
the creation of the EPA, the Toxic 
Substances Control Act was passed 
by Congress. This Act gave the EPA 
the power to control chemicals that 
pose an unreasonable risk to human 
health or the environment. In other 
words, the EPA was charged with 
determining the safe human exposure 
level for chemicals. Since taking on 
this daunting task of monitoring the 
roughly 75,000 chemicals produced 
in or imported into the US, the EPA 
has taken action to reduce the risk of 
over 3,600 chemicals but has banned 
or limited the production or use of 
only ﬁ  ve. Currently, the EPA lists 
the “safe level” for BPA as being 50 
micrograms (or 0.00005 grams) of BPA 
per kilogram of body weight per day 
[21]. Following this guideline, a person 
weighing 140 pounds (approximately 
63 kg) could “safely” ingest 0.003 grams 
of BPA per day, or a little over a gram 
of BPA each year. This “safe” level is 
much higher than the low doses to 
which people are routinely exposed. 
At this point, you might be 
wondering why this is the ﬁ  rst time 
you’ve ever heard of BPA. The 
information is out there but it is a 
puzzle to get through. Early studies 
indicated that BPA did not leach or 
leached in very small amounts from 
plastic products, including baby bottles. 
These studies are often referred to by 
those in the chemical industry, such as 
the American Plastics Council—who 
have a vested interest in maintaining 
the use of BPA in plastics production, 
to verify the safety of the products 
[22]. However, since 1999 many 
studies have shown that BPA leaches 
from products at levels known to 
cause health effects in animals. Earlier 
studies on BPA exposure also tended 
to ﬁ  nd little resulting adverse health 
effects, yet these studies were often 
using doses that were higher than 
those now regarded as being in an 
environmentally relevant range—that 
is, the low doses that humans are 
exposed to regularly and that ﬁ  t within 
the so-called “low-dose theory” that 
claims that lower doses can be more 
harmful than higher doses [23,24]. 
These were the main studies initially 
used by the EPA to determine the 
“safe” level of BPA exposure and that 
are often referenced to attest to the 
safety of BPA [21,22]. 
Because of this ambiguity, ﬁ  ndings 
can be obscured by those who inform 
the public, especially those with a 
vested interest in BPA production and 
usage. As a result, the media presents 
a confusing and unclear picture of 
the health risks of BPA exposure by 
giving equal weight to statements 
from independent scientists and those 
working for industry. The resulting 
inﬂ  uence of this ambiguity was recently 
revealed in the spring of 2006 when 
US state legislators in California, 
Maryland, and Minnesota attempted to 
pass legislation that would ban the use 
of BPA in products aimed at children. 
None of them passed.
The bills focused on children 
because they are far more susceptible 
to adverse affects from chemical 
exposures than adults, even at very 
low doses. The biological processes 
involved in their ongoing development 
are vulnerable to disruption by BPA 
and their ability to metabolically 
detoxify such contaminants is not yet 
mature. Moreover, children are more 
likely to be exposed to BPA orally 
because of their need to put things 
in their mouth—a purpose for which 
some BPA-containing products, such as 
some baby bottles and teething rings, 
are speciﬁ  cally designed.
The California bill (AB319) was 
introduced in February 2005, making 
it the ﬁ  rst such legislation to be 
introduced in any state. Sponsored 
by Assembly Member Wilma Chan 
(Democrat), AB319 called for any BPA-
containing products, including toys 
or childcare articles, intended for use 
by a child 3 years old or younger to be 
prohibited in the state. (It also sought 
to ban other harmful chemicals such 
as phthalates.) Violators of the ban 
would face civil action, carried out by 
the Attorney General, and penalties 
of no less then US$10,000 for each 
day of violation [25]. The fact sheet 
accompanying the bill states, “AB319 
recognizes that we must act now to 
prevent exposure by eliminating at 
the source the chemicals, such as 
Bisphenol-A and Phthalates that pollute 
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our bodies. By making intelligent 
decisions about what chemicals we 
allow into the environment, we can 
prevent unnecessary exposures to 
dangerous substances. Furthermore, 
children are incredibly sensitive to 
chemical pollution…. Some chemicals 
are simply too toxic and dangerous 
to children, to allow exposures to 
continue.”
The bill was energetically opposed by 
stakeholders in the chemical, plastics, 
baby products, and grocery industries. 
Under the umbrella organization 
Coalition for Consumer Choice, the 
NoAB319 campaign successfully fought 
the bill both in the media and in the 
Assembly hearing. In a news release 
by NoAB319, Steve Hentges, executive 
director of the Polycarbonate Business 
Unit of the American Plastics Council, 
stated that the legislation was “founded 
on insubstantial claims and unproven 
hypotheses that lack scientiﬁ  c rigor.” 
The contradictory information set 
forth by the proponents and opponents 
of the bill ultimately led to its death in 
the Appropriations Committee, even 
after an amendment removed the 
BPA provisions, because of one vote. 
San Francisco Democrat Leland Yee, 
according to a spokesman, “decided 
that the decisions to ban chemicals 
should be left to health experts, not 
politicians, especially after scientists 
gave conﬂ  icting testimony at an 
Assembly hearing last week.” [26]. 
Fortunately, Chan intends to resubmit 
the bill and Yee said he “would support 
a new bill if it authorized state health 
ofﬁ  cials to evaluate the risks and make 
the decision.” [26].
At a more local level, the ﬁ  rst 
legislation to ban BPA from products 
aimed at children passed in the city of 
San Francisco. The “Stop Toxic Toys” 
bill was virtually identical to AB319 
and was signed into law on June 16, 
2006.  However, in April 2007, the 
clause limiting BPA in child-aimed 
products was repealed pending action 
at the state level. As a result, no action 
on BPA-containing products will occur 
in the city until January 2008, and 
only then if the state has not taken 
appropriate actions to reduce its use 
at the state level. While the initial San 
Francisco legislation was an important 
step, such a piecemeal approach to 
controlling BPA exposure, especially 
in young children, is not perfect. 
Companies and businesses are bound 
to have difﬁ  culty conforming to a 
variety of regulations. Although BPA-
free alternatives are often available, 
consumers in areas with legislation may 
ﬁ  nd a lack of choices when it comes to 
plastic products on the store shelves. 
Ideally the national regulatory agencies 
should step in to minimize these 
problems. 
At the national level, the White 
House disputes the “low-dose theory” 
and has proposed funding cuts for 
EPA research on endocrine disrupting 
chemicals such as BPA; however, 
the US Congress has maintained 
the funding level [27]. The EPA has 
revisited safe exposure levels of other 
chemicals. For example, in 2001, the 
EPA reduced the allowable level of 
arsenic in drinking water from 50 ppb 
to 10 ppb. It should do the same for 
BPA.
Currently, both the EPA and the 
European Food Safety Authority 
(EFSA) have set the “safe” level of 
exposure to BPA to 0.00005 grams 
per kilogram of body weight per 
day. Although difﬁ  cult to estimate 
accurately, humans are typically 
exposed to about 0.000001 grams of 
BPA per kilogram of body weight per 
day. This is 50 times lower than the 
EPA- and EFSA-deemed “safe” limit. 
Unfortunately, this level of exposure 
is still signiﬁ  cantly higher than the low 
doses that some studies have shown to 
cause adverse health effects. Moreover, 
the levels of BPA found by the Center 
for Disease Control and Prevention to 
be present in the bodies of Americans 
appear to be too high to be explained 
by exposure to known sources of BPA 
[7]. Thus, there is a clear need for 
further health studies on BPA exposure 
and for regulatory agencies to continue 
to monitor the science behind the 
politics. An attentive assessment of 
the risk of human exposure to BPA 
may prompt the plastics industry and 
manufacturers of products containing 
BPA to reevaluate their use of BPA and 
opt for BPA-free alternatives.  
In the meantime, what is the 
scientist-mother to do? The mother 
in me still waits anxiously for the 
regulatory agencies and the legislature 
to catch up with the research on BPA 
that the scientist in me appreciates. I 
have switched my brand of sippy cups 
to one that doesn’t contain BPA (a 
quick internet search will yield many 
sites describing these and other BPA-
free baby products). Nevertheless, 
while I feel proactive as I watch my 
daughter happily drink her water, I still 
cringe a little bit when she drops the 
sippy cup, toddles over to her toy bin, 
and starts to gnaw on her plastic turtle 
instead.  
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